Vijaya Diagnostic CEN LTD
Vijaya Diagnostic Cen Ltd (VIJAYA): company summary
The company's annual revenue rose 19.6% to ₹814 crore, while annual net profit increased 20.1% to ₹173 crore.
Vijaya Diagnostic Cen Ltd (VIJAYA) is a small-cap Healthcare company valued at ₹14,231 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Vijaya Diagnostic Cen Ltd last traded at ₹1,387.9, modestly up 0.04% on the day.
- Recent developments
- On 2026-06-30, the company reported its latest quarter results, showing strong growth in both revenue and net profit compared to the same period last year. Promoter holding remained at 52.51%, with 1.96% of promoter shares pledged. Foreign institutional holding decreased by 1.72 points to 11.66%, while domestic institutional holding increased by 1.68 points to 31.61%.
- Financial performance
- The company's annual revenue rose 19.6% to ₹814 crore, while annual net profit increased 20.1% to ₹173 crore. The latest quarter saw revenue rise 22.9% to ₹231 crore and net profit jump 36.2% to ₹53 crore, outpacing the same quarter a year earlier.
- Valuation multiples
- The stock trades at 82.6 times earnings, a premium to the Healthcare median of 32.0, 16.12 times book value. It yields 0.1%.
- Things to watch
- The stock is 10.4% below its 52-week high. The company's market cap is ₹14,694 crore, classifying it as a small-cap stock. Promoter shares pledged amount to 1.96% of promoter holding.
- Where it stands
- The company's latest quarter revenue and net profit both grew significantly compared to the same quarter a year earlier. The stock is 10.4% below its 52-week high, and promoter shares pledged amount to 1.96% of promoter holding.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (9.3) and quality (8.1), but held back by valuation (0.0). Risk looks strong at 9.3, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profitable in all of the last 5 years
- Healthy net margin (21%)
- Strong returns on equity (18%)
- Valuation is weak (0.0/10)
- Expensive at 83× earnings
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Healthcare Service Provider
Explore VIJAYA DIAGNOSTIC CEN LTD’s valuation
Free deep-dive tools · no sign-up
VIJAYA DIAGNOSTIC CEN LTD peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare VIJAYA DIAGNOSTIC CEN LTD with peers
Related tools & concepts
Value VIJAYA DIAGNOSTIC CEN LTD with the ratios and calculators DocStoX uses in its analysis.

